论文部分内容阅读
目的分析对类风湿关节炎患者采用云克(通用名:锝[99Tc]亚甲基二膦酸盐注射液)联合来氟米特进行治疗的临床疗效,进而提高类风湿关节炎患者的生存质量。方法 80例类风湿关节炎患者随机分为实验组和对照组,各40例。对照组仅采用来氟米特治疗,实验组则使用云克联合来氟米特治疗。观察两组疗效。结果实验组总有效率为97.5%,而对照组总有效率为85.0%。对照组和实验组比较,差异具有统计学意义(P<0.05)。结论云克联合来氟米特可以有效缓解类风湿关节炎患者的肿痛症状及炎症指标,二者合用有协同作用,效果显著,具有一定的临床应用价值和广阔的发展前景。
Objective To analyze the clinical efficacy of Yunke (common name: technetium [99Tc] methylene diphosphonate injection) in combination with leflunomide in patients with rheumatoid arthritis to improve the quality of life in patients with rheumatoid arthritis . Methods Eighty patients with rheumatoid arthritis were randomly divided into experimental group and control group, 40 cases each. In the control group, only leflunomide was used, and in the experimental group, Yunke combined with leflunomide was used. The two groups were observed. Results The total effective rate in the experimental group was 97.5%, while the total effective rate in the control group was 85.0%. The difference between the control group and the experimental group was statistically significant (P <0.05). Conclusions Yunke combined with leflunomide can effectively relieve the swelling and pain symptoms and inflammation index in patients with rheumatoid arthritis. The combination of both has synergistic effect with significant effect and has certain clinical value and broad prospects for development.